• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一些老年正常受试者中,大脑中的早期补体激活增加。

Early complement activation increases in the brain in some aged normal subjects.

作者信息

Loeffler David A, Camp Dianne M, Schonberger Michael B, Singer Daniel J, LeWitt Peter A

机构信息

Division of Neurology, William Beaumont Hospital Research Institute, Royal Oak, MI 48073, USA.

出版信息

Neurobiol Aging. 2004 Sep;25(8):1001-7. doi: 10.1016/j.neurobiolaging.2003.11.003.

DOI:10.1016/j.neurobiolaging.2003.11.003
PMID:15212824
Abstract

Complement activation is increased in Alzheimer's disease (AD) and may contribute to the development and progression of this disorder. To compare early complement activation between normal and AD brain specimens, C4d and iC3b concentrations were measured in hippocampus, entorhinal cortex, temporal cortex, parietal cortex, and cerebellum from aged normal and AD subjects n=10-14 for both), and in hippocampus and entorhinal cortex from younger normal subjects (n=5-6). C4d and iC3b levels increased 2.3- to 4.6-fold in AD versus aged normal specimens (all P <0.05), with lowest concentrations of these activation proteins generally in cerebellum. No significant differences were present between aged and younger normal C4d and iC3b levels in hippocampus or entorhinal cortex. However, the concentrations of these proteins were markedly increased in several aged normal specimens. Normal subject age was moderately associated with both C4d (r=0.49) and iC3b (r=0.53) concentrations in the hippocampus. Increased brain complement activation in some elderly individuals may promote the subsequent development of AD.

摘要

阿尔茨海默病(AD)中补体激活增加,可能促使该疾病的发生和发展。为比较正常脑标本与AD脑标本的早期补体激活情况,对老年正常受试者和AD受试者(两组均为n = 10 - 14)的海马体、内嗅皮质、颞叶皮质、顶叶皮质及小脑,以及年轻正常受试者(n = 5 - 6)的海马体和内嗅皮质中的C4d和iC3b浓度进行了测量。与老年正常标本相比,AD标本中的C4d和iC3b水平升高了2.3至4.6倍(所有P < 0.05),这些激活蛋白的浓度通常在小脑中最低。在海马体或内嗅皮质中,老年正常受试者与年轻正常受试者的C4d和iC3b水平无显著差异。然而,在一些老年正常标本中,这些蛋白的浓度显著升高。正常受试者的年龄与海马体中C4d(r = 0.49)和iC3b(r = 0.53)的浓度呈中度相关。一些老年人脑内补体激活增加可能会促使随后AD的发生。

相似文献

1
Early complement activation increases in the brain in some aged normal subjects.在一些老年正常受试者中,大脑中的早期补体激活增加。
Neurobiol Aging. 2004 Sep;25(8):1001-7. doi: 10.1016/j.neurobiolaging.2003.11.003.
2
Up-regulated production and activation of the complement system in Alzheimer's disease brain.阿尔茨海默病大脑中补体系统的产生和激活上调。
Am J Pathol. 1999 Mar;154(3):927-36. doi: 10.1016/S0002-9440(10)65340-0.
3
[Immunohistochemical appearance of complement protein, C4d, in the nervous system and its significance].[补体蛋白C4d在神经系统中的免疫组化表现及其意义]
No To Shinkei. 1998 Feb;50(2):137-45.
4
Calpastatin levels affect calpain activation and calpain proteolytic activity in APP transgenic mouse model of Alzheimer's disease.在阿尔茨海默病的淀粉样前体蛋白(APP)转基因小鼠模型中,钙蛋白酶抑制蛋白水平会影响钙蛋白酶的激活及钙蛋白酶的蛋白水解活性。
Neurochem Int. 2007 Nov-Dec;51(6-7):391-7. doi: 10.1016/j.neuint.2007.04.004. Epub 2007 Apr 19.
5
Expression of cortical and hippocampal apoptosis-inducing factor (AIF) in aging and Alzheimer's disease.衰老和阿尔茨海默病中皮质及海马区凋亡诱导因子(AIF)的表达
Neurobiol Aging. 2007 Mar;28(3):351-6. doi: 10.1016/j.neurobiolaging.2006.01.003. Epub 2006 Feb 28.
6
[Brain volume changes of patients with Alzheimer's disease in two years: a case control study].阿尔茨海默病患者两年内脑容量变化:一项病例对照研究
Zhonghua Yi Xue Za Zhi. 2008 Apr 15;88(15):1027-31.
7
Discriminating accuracy of medial temporal lobe volumetry and fMRI in mild cognitive impairment.内侧颞叶容积测量和功能磁共振成像在轻度认知障碍中的鉴别准确性
Hippocampus. 2009 Feb;19(2):166-75. doi: 10.1002/hipo.20494.
8
Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels.阿尔茨海默病和正常大脑中中性内肽酶的年龄依赖性下降:与β淀粉样蛋白水平呈负相关。
Neurobiol Aging. 2008 Feb;29(2):210-21. doi: 10.1016/j.neurobiolaging.2006.10.010. Epub 2006 Nov 13.
9
Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.大鼠内嗅皮质中的β-淀粉样蛋白病变会引发记忆缺陷:对阿尔茨海默病的启示。
Neuroscience. 2007 Jun 15;147(1):28-36. doi: 10.1016/j.neuroscience.2007.04.011. Epub 2007 May 17.
10
Altered expression of COX-2 in subdivisions of the hippocampus during aging and in Alzheimer's disease: the Hisayama Study.衰老及阿尔茨海默病患者海马亚区中COX-2表达的改变:久山町研究
Dement Geriatr Cogn Disord. 2007;23(6):423-31. doi: 10.1159/000101957. Epub 2007 Apr 23.

引用本文的文献

1
Deficiency of terminal complement pathway inhibitor promotes neuronal tau pathology and degeneration in mice.末端补体途径抑制剂缺乏促进小鼠神经元 tau 病理和变性。
J Neuroinflammation. 2012 Sep 18;9:220. doi: 10.1186/1742-2094-9-220.
2
Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease.鉴定和验证新型脑脊液生物标志物用于早期阿尔茨海默病的分期。
PLoS One. 2011 Jan 12;6(1):e16032. doi: 10.1371/journal.pone.0016032.
3
Genetic control of the alternative pathway of complement in humans and age-related macular degeneration.
人类补体旁路的遗传控制与年龄相关性黄斑变性。
Hum Mol Genet. 2010 Jan 1;19(1):209-15. doi: 10.1093/hmg/ddp472.
4
The complement cascade: Yin-Yang in neuroinflammation--neuro-protection and -degeneration.补体级联反应:神经炎症中的阴阳——神经保护与神经退变
J Neurochem. 2008 Dec;107(5):1169-87. doi: 10.1111/j.1471-4159.2008.05668.x. Epub 2008 Oct 24.
5
Rapid complete response using intrathecal rituximab in a patient with leptomeningeal lymphomatosis due to mantle cell lymphoma.鞘内注射利妥昔单抗治疗套细胞淋巴瘤所致柔脑膜淋巴瘤患者实现快速完全缓解
Anticancer Drugs. 2008 Oct;19(9):917-20. doi: 10.1097/CAD.0b013e32830cebc1.
6
Evidence that immunoglobulin-positive neurons in Alzheimer's disease are dying via the classical antibody-dependent complement pathway.阿尔茨海默病中免疫球蛋白阳性神经元通过经典抗体依赖性补体途径死亡的证据。
Am J Alzheimers Dis Other Demen. 2005 May-Jun;20(3):144-50. doi: 10.1177/153331750502000303.
7
Using animal models to determine the significance of complement activation in Alzheimer's disease.利用动物模型确定补体激活在阿尔茨海默病中的意义。
J Neuroinflammation. 2004 Oct 12;1(1):18. doi: 10.1186/1742-2094-1-18.